Expression of Fhit, Mlh1, p16INK4A and E-cadherin in early gastric neoplasia: Correlation with histological grade and gastric phenotype

Oncology Reports

Volumn 18, Issue 3, 2007, Pages 553-559

  Hara, Akihito ^a   Yashima, Kazuo ^a   Yasugi, Akiko ^a   Koda, Masaharu ^a   Kawaguchi, Koichiro ^a   Harada, Kenichi ^a   Andachi, Hironobu ^a   Shiota, Goshi ^a   Ito, Hisao ^a   Murawaki, Yoshikazu ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

E cadherin; Fhit; Gastric neoplasia; Mlh1; Mucin phenotype; p16

Indexed keywords

ACID ANHYDRIDE HYDROLASE; CADHERIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FRAGILE HISTIDINE TRIAD PROTEIN; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADENOMA; AGED; ARTICLE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; MALE; MIDDLE AGED; PATHOLOGY; PHENOTYPE; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOMA; AGED; CADHERINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; STOMACH NEOPLASMS;

EID: 38449116928     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.3.553     Document Type: Article

References (39)

1. Yasui W, Oue N, Ono S, Mitani Y, Ito R and Nakayama H: Histone acetylation and gastrointestinal carcinogenesis. Ann NY Acad Sci 983: 220-231, 2003. (Pubitemid 36399335)
2. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, Aung PP, Kuraoka K, Nakayama H and Yasui W: Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis and carcinogenesis by serial analysis of gene expression. Cancer Res 64: 2397-2405, 2004. (Pubitemid 38523892)
3. Kang GH, Lee S, Kim J-S and Jung H-Y: Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest 83: 635-641, 2003. (Pubitemid 36618042)
4. Tamura G: Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. Histol Histopathol 19: 221-228, 2004.
5. Kim TY, Jong H-S, Jung Y, Kim T-Y, Kang GH and Bang Y-J: DNA hypermethylation in gastric cancer. Aliment Pharmacol Ther 20 (Suppl.1): S131-S142, 2004.
6. Kolodziejczyk P, Yao T, Oya M, Nakamura S, Utsunomiya T, Ishikawa T and Tsuneyoshi M: Long-term follow-up study of patients with gastric adenomas with malignant transformation: an immunohistochemical and histochemical analysis. Cancer 74: 2896-2907, 1994. (Pubitemid 24361073)
7. Orlowska J, Jarosz D, Pachlewski J and Butruk E: Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol 90: 2152-2159, 1995.
8. Kang GH, Shim YH and Ro JY: Correlation of methylation of the hMLH1 promoter with lack of expression of hMLH1 in sporadic gastric carcinomas with replication error. Lab Invest 79: 903-909, 1999. (Pubitemid 29344503)
9. Leung SY, Yuen ST, Chung LP, Chu KM, Chan ASY and Ho JCI: hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 59: 159-164, 1999. (Pubitemid 29062972)
10. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y and Imai K: Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 83: 309-313, 1999. (Pubitemid 29455752)
11. Shim YH, Kang GH and Ro JY: Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 80: 689-695, 2000. (Pubitemid 30340653)
12. Song SH, Jong H-S, Choi HH, Kang SH, Ryu MH, Kim W-H and Bang Y-J: Methylation of specific CpG sites in the promoter region could significantly down-regulate p16INK4a expression in gastric adenocarcinoma. Int J Cancer 87: 236-240, 2000. (Pubitemid 30434352)
13. Fleisher AS, Esteller M, Tamura G, Rashid A, Stine OC, Yin J, Zou T-T, Abraham JM, Kong D, Nishizuka S, James SP, Wilson KT, Herman JG and Meltzer SJ: Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in human early gastric neoplasia. Oncogene 20: 329-335, 2001. (Pubitemid 32142322)
14. Graziano F, Arduini F, Ruzzo A, Mandolesi A, Bearzi I, Silva R, Muretto P, Testa E, Mari D, Magnani M, Scartozzi M and Cascinu S: Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol 15: 489-492, 2004. (Pubitemid 38444555)
15. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue PA, Druck T, Croce CM and Huebner K: The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597, 1996. (Pubitemid 26071739)
16. Baffa R, Veronese ML, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM and Huebner K: Loss of FHIT expression in gastric carcinoma. Cancer Res 58: 4708-4714, 1998. (Pubitemid 28480639)
17. Capuzzi D, Santoro E, Hauck WW, Kovatich AJ, Rosato FE, Baffa R, Huebner K and McCue PA: Fhit expression in gastric adenocarcinoma: Correlation with disease stage and survival. Cancer 88: 24-34, 2000. (Pubitemid 30027675)
18. Noguchi T, Takeno S, Kimura Y, Uchida Y, Daa T, Yokoyama S, Gabbert HE and Mueller W: FHIT expression and hypermethylation in esophageal squamous cell carcinoma. Int J Mol Med 11: 441-447, 2003.
19. Wu Q, Shi H, Suo Z and Nesland JM: 5′-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas. Ultrastruct Pathol 27: 417-422, 2003. (Pubitemid 38041328)
20. Iliopoulos D, Guler G, Han S-Y, Johnston D, Druck T, McCorkell KA, Palazzo J, McCue PA, Baffa R and Huebner K: Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene 24: 1625-1633, 2005. (Pubitemid 40396092)
21. Lauren P: The two main histological types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64: 31-49, 1965.
22. Nakamura K, Sugano H and Takagi K: Carcinoma of the stomach in incipient phase: its histogenesis and histological appearance. Gann 59: 251-258, 1968.
23. Egashira Y, Shimoda T and Ikegami M: Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 49: 55-61, 1999. (Pubitemid 29421948)
24. Yoshino T, Shimoda T, Saito A, Nakanishi Y, Tajima Y, Shirasu T and Miura S: Macroscopic features of differentiated adenocarcinoma with gastric or intestinal phenotype expression in early gastric cancer. Stomach Intestine 34: 513-525, 1999.
25. Koseki K, Takizawa T, Koike M, Ito M, Nihei Z and Sugihara K: Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 89: 724-732, 2000. (Pubitemid 30658569)
26. Koseki K, Takizawa T, Koike M, Funata N, Hishima T, Sakoma T, Moriyama S, Okamoto H, Hayashi S, Iwasaki Y and Arai K: Subclassification of well-differentiated gastric cancer with reference to biological behavior and malignancy, gastric type vs. intestinal type, and papillary carcinoma vs. tubular carcinoma. Stomach Intestine 34: 507-512, 1999.
27. Endoh Y, Tamura G, Sakata K, Ohmura K, Watanabe E and Motoyama T: Genetic analysis of differentiated-type adenocarcinomas of the stomach with gastric phenotype and intestinal phenotype. Stomach Intestine 34: 539-544, 1999.
28. Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M and Kumagai K: Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 61: 212-220, 2001. (Pubitemid 34701536)
29. Kabashima A, Yao T, Sugimachi K and Tsuneyoshi M: Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinoma. Hum Pathol 33: 80-86, 2002. (Pubitemid 34112955)
30. Japanese Research Society for Gastric Cancer. The General Rules for Gastric Cancer Study, 21st edition. Kanehara Publication, Tokyo, 1993.
31. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou JF, Geboes K, Hattori T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H and Yamabe H: The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47: 251-255, 2000. (Pubitemid 30489769)
32. Hao XP, Willis JE, Pretlow TG, Rao JS, MacLnnan GT, Talbot IC and Pretlow TP: Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer Res 60: 18-21, 2000. (Pubitemid 30058722)
33. Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H and Yasui W: Accumulation of DNA methylation is associated with tumor stage in gastric cancer. Cancer 106: 1250-1259, 2006. (Pubitemid 43363901)
34. Lee HS, Lee HK, Kim HS, Yang HK and Kim WH: Tumour suppressor gene expression correlates with gastric cancer prognosis. J Pathol 200: 39-46, 2003. (Pubitemid 36592634)
35. Lee J-H, Park S-J, Abraham SC, Seo J-S, Nam J-H, Choi C, Juhng S-W, Rashid A, Hamilton SR and Wu T-T: Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 23: 4646-4654, 2004. (Pubitemid 38850413)
36. Sun Y, Deng D, You W-C, Bai H, Zhang L, Zhou J, Shen L, Ma J-L, Xie Y-Q and Li J-Y: Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study. Clin Cancer Res 10: 5087-5093, 2004. (Pubitemid 39099783)
37. Endoh Y, Tamura G, Ajioka Y, Watanabe H and Motoyama T: Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype. Am J Pathol 157: 717-722, 2000. (Pubitemid 32109363)
38. Motoshita J, Oue N, Nakayama H, Kuraoka K, Aung PP, Taniyama K, Matsusaki K and Yasui W: DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes. Cancer Sci 96: 474-479, 2005. (Pubitemid 41387299)
39. Tsukashita S, Kushima R, Bamba M, Sugihara H and Hattori T: MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer 94: 166-170, 2001. (Pubitemid 32911408)